Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model

Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model

Background: Heart failure (HF) affects around 500,000 people in the UK. HF medications are frequently underprescribed and B-type natriuretic peptide (BNP)-guided therapy may help to optimise treatment. Objective: To evaluate the clinical effectiveness and cost-effectiveness of BNP-guided therapy com...

Full description

Bibliographic Details
Main Authors: Maria Pufulete, Rachel Maishman, Lucy Dabner, Syed Mohiuddin, William Hollingworth, Chris A Rogers, Julian Higgins, Mark Dayer, John Macleod, Sarah Purdy, Theresa McDonagh, Angus Nightingale, Rachael Williams, Barnaby C Reeves
Format: Article
Language:English
Published: NIHR Journals Library 2017-08-01
Series:Health Technology Assessment
Subjects:
heart failure
b-type natriuretic peptide
bnp
nt-probnp
bnp-guided therapy
bnp monitoring
heart failure reduced ejection fraction
hfref
heart failure preserved ejection fraction
hfpef
systematic review
ipd meta-analysis
cohort study
clinical practice research datalink
national heart failure audit
cost-effectiveness model
Online Access:https://doi.org/10.3310/hta21400

Internet

https://doi.org/10.3310/hta21400

Similar Items